母亲AMPK通路的激活与子宫动脉血流和胎儿在缺氧期间的生长维护
Lorna G Moore1, Ramón A Lorca1, Diane L Gumina1,2
1Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States.
概括
高海拔怀孕会减少子宫动脉的血流和出生体重. 增加AMP激活蛋白激酶 (AMPK) 路径基因表达,特别是PRKAA1,与更好的子宫动脉功能和胎儿生长相关,可能减轻缺氧效应.
科学领域:
- 生殖生理学 生殖生理学
- 高度医学 高度医学
- 胎儿的发育 胎儿的发育
背景情况:
- 高海拔 (HA) 缺氧会损害子宫动脉 (UtA) 的血液流动,并降低怀孕期间的出生体重.
- AMP激活蛋白激酶 (AMPK) 激活表现出子宫胎盘血管扩张作用,可能抵消低氧诱导的出生体重减少.
研究的目的:
- 调查AMPK通路基因表达与在HA中母亲循环中的代谢物之间的关系.
- 确定AMPK通路活性与UtA血流和HA怀孕中出生体重维持的关联.
主要方法:
- 在HA (2,793米) 和低海拔 (LA; 1,640米) 的女性之间比较UtA直径,血流,出生体重和AMPK通路基因表达.
- 对PRKAA1基因表达与UtA参数和妊娠中期和晚期胎儿生物学的相关性分析.
主要成果:
- 与洛杉矶居民相比,HA居民的UtA直径较小,20周 UtA血流量较低,出生体重较低.
- 在第34周,HA女性显示上游和下游AMPK通路基因的表达减少.
- PRKAA1基因表达与UtA直径和血液流量 (20周在HA;34周在LA) 呈正相关,下游基因表达与胎儿生物识别和出生体重相关.
结论:
- 在HA怀孕中AMPK通路基因表达的减少可能导致UtA功能受损和胎儿生长.
- PRKAA1表达和UtA血流之间的积极相关性表明,在妊娠中期增强的AMPK激活灵敏度可能会减轻低氧对胎儿生长的有害影响.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
cAMP-dependent Protein Kinase Pathways
6.2K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Teratogenicity
2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K


